RXONYSE United States
Market cap
$3.579 B
$21.70 +7.21%
Close of 7 Aug 2026
Revenue
$5.74B
#613 by revenue
Earnings
-$100.0M
Loss-making
Shares outstanding
164,926,128
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for RXO are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.